Blog Articles

Creating and producing advanced drug-device combinations, like autoinjectors and pen injectors, requires a depth and breadth of technical expertise. As more pharmaceutical companies streamline their supply chains and outsource specialised technical tasks, these challenges are increasingly being shifted to their development partners.

Advances in precision medicine and diagnostics over the past decade have the potential to improve patient outcomes by decreasing the time needed to identify a disease or pathogen and adjust patient treatment, whether they are to address rising cases of antibiotic resistance, viral epidemics or facilitate more tailored cancer therapy. The ever-accelerating development in this area can be attributed to rapid advances in microfluidic devices, nucleic acid amplification, synthetic biology, battery…

There are few experiences that can surpass the joy of seeing a product you developed reach manufacture. But before that, you face the non-trivial task of proving your current embodiment can actually work and meet its design intent. This stage, often referred to as the “proof of feasibility,” serves as a bridge between conceptualization and detailed development, providing crucial evidence that your approach is the right one and will result in a safe, compliant, and effective product.

We are pleased to announce an enhancement to our human factors capabilities with the introduction of our new dedicated human factors facility. With only a few available in the area, this gives our clients easier and faster access to custom-built facilities.

Closed-loop insulin delivery systems, also known as artificial pancreas systems, are currently in an exciting phase of technological innovation and transformation, and look set to transform the management of diabetes for the future. These innovations are driven by enhancements in sensing and delivery technology, promising clinical trial results, and new regulatory approvals.

In a recent panel discussion, our Material Scientist, Catriona Eldridge spoke about the importance of collaboration and team influence on designing medical devices with sustainability in mind. Here, we see how she has expanded a core theme from the panel.

The pharmaceutical industry is currently undergoing a period of rapid innovation, propelled by several factors. These include advancements in the development of biologics, which are becoming increasingly diverse1, decentralized healthcare practices, and a shift towards administering injections less frequently in home settings2. Additionally, small molecules are being designed through AI drug discovery techniques3. While these therapeutic innovations hold promise, they can also bring forth…

In the October 2022 “Drug Delivery & Environmental Sustainability” issue of ONdrugDelivery, We discussed climate-related targets set by 10 major pharmaceutical companies, along with progress towards these targets and their history of meeting previous environmental and climate-related goals.(1)

Mike Beck, our Head of Electronics spent some time in Boston at the Device Talks Conference last week. Here are his take aways.

Forensic medical device engineering is a high-stakes discipline, where experts investigate and analyse medical devices that have malfunctioned, failed, or caused adverse events. These issues can have far-reaching consequences, from endangering patient safety to affecting legal proceedings and the reputation of medical device manufacturers. Solving these challenging problems requires a robust, systematic approach to identify root causes and implement effective solutions.